Received: 26 April 2022
Accepted: 23 February 2023
First Online: 6 March 2023
: Not applicable. This project was submitted for review through Advocate Health and was waived as this study was deemed non-human subject related research.
: Not applicable.
: Dr. Eli Ehrenpreis serves as the Chief Executive Officer of E2Bio Life Sciences, a company that is developing Bocaliner, a medical device to improve the treatment of oral mucositis which is a complication of chemotherapy, patent pending. Dr. Ehrenpreis has no additional competing interests to disclose. Dr. Hardeep S. Ahdi, Dr. Thomas Adam Wichelmann and Dr. Sasirekha Pandravada have no competing interests to disclose.